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The microbiome heavily influences the metabolism of its host. In this issue of Cell Metabolism, Donohoe
and colleagues demonstrate that microbial butyrate, used as a fuel metabolite, prevents autophagy in
colonocytes, showing that the microbial-mammalian metabolic axis goes beyond simple metabolism.Symbiotic gut bacteria actively participate
in their mammalian host’s physiology and
health. It is estimated that in a healthy
human adult, microbial cells outnumber
human cells by 10-fold, and the total
genetic contribution of these microbial
cells (>100,000 genes) may provide
essential traits not encoded in our
genome, but rather outsourced in our
‘‘extended genome’’ (Lederberg, 2004;
Nicholson et al., 2004). The extended
genome tenet states that we are the sum
of all our genetic contributions: the
karyome (chromosomes), the chondriome
(mitochondrialDNA, evolutionary inherited
from internalized symbiotic bacteria),
and the microbiome (DNA from our gut
symbiotic bacterial community). Owing to
international efforts in high-throughput
sequencing and annotation of bacterial
genomes, our understanding of ourmicro-
bial genetic counterpart has dramatically
increased during the last decade (Nelson
et al., 2010; Qin et al., 2010; Turnbaugh
et al., 2007). The microbiome performs
digestive and metabolic functions for
the human host, including enhanced
calorific recovery from ingested foods
anddegradation of plant polysaccharides.
Up to40%energy intake isprovidedby the
gut microbiota (Ba¨ckhed et al., 2004). In
fact, germ-free animals are considered to
be in an energy-deprived state, with a shift
in mitochondrial metabolism, character-
ized by reduced expression and activity
of mitochondrial TCA cycle enzymes and
a reduced NADH/NAD+ balance, resulting
in a lower oxidative phosphorylation
and eventually lower ATP production.
Mitochondria are central to mammalian
metabolism, oxidizing fuel metabolites
such as glucose, amino acids, or fatty
acids through the TCA cycle reducingNAD+ into NADH, ultimately generating
the intramembrane proton gradient to
produce ATP, the almost universal energy
metabolite required for cellular functions.
An energy-deprived cell struggling to
sustain ATP levels usually reallocates
nutrients from futile to essential processes
through autophagy, the digestion of
cellular constituents by its own enzymes.
The autophagosome, a membrane
isolating a cellular region from the rest of
the cytosol, fuses with lysosomes to
degrade their content.
In this issue of Cell Metabolism, Dono-
hoe et al. (2011) dissect the role of the
microbiome and butyrate in the regulation
of energy metabolism. Using germ-free
(GF) mice, they demonstrate that colono-
cytes, the mucosal cells at the interface
between the gut bacteria in the lumen
and the host’s systemic circulation, use
bacterial butyrate as a fuel metabolite in
mitochondria, increasing NADH/NAD+
balance and ATP levels, which ultimately
prevents autophagy (Figure 1). They first
compare energy homeostasis and redox
balance of different tissues (liver, heart,
kidney, testis, and colon) from both
GF and conventionally raised (CONV-R)
mice, and show that NADH/NAD+
balance and ATP levels are dramatically
lower in the mitochondria of GF colono-
cytes. A characterization of the transcrip-
tome, proteome, and metabolome of GF
and CONV-R colonocytes confirms
downregulation of TCA cycle enzymes.
As a result of this downregulation, GF
colonocytes exhibit diminished oxidative
phosphorylation, producing 31% less
13CO2 than CONV-R colonocytes in a
13C-butyrate isotopic enrichment experi-
ment—a staggering figure confirmed by
LC-MS and confocal microscopy. ThisCell Metabolisenergetic stress is characterized by high
levels of phosphorylated AMPK, which is
a sensor of energy deprivation, and
p27kip1 activation that triggers autophagy
in GF colonocytes, as revealed by the
presence of double-membrane autopha-
gosomes using transmission electron
microscopy.
Capitalizing on the evidence from these
GF experiments, Donohoe et al. (2011)
next show that Butyrivibrio vibriosolvens,
a butyrate-producing bacterium, rescues
mitochondrial homeostasis when colo-
nizing GF animals. The ex vivo effects
of butyrate on GF colonocytes consist
of raising oxidative phosphorylation to
30%–70% of CONV-R colonocyte levels,
which in turn prevents autophagy through
significant decreased p27kip1 phosphory-
lation. This result itself is extremely
important, as it shows that butyrate
supplementation can correct the physi-
ology of energy-deprived colonocytes.
To test whether these effects were
caused by the histone deacetylase
(HDAC) inhibitor properties of butyrate
(Candido et al., 1978) or by the use of
butyrate as a fuel metabolite, Donohoe
et al. implemented two complementary
experiments. A pharmacological interven-
tion with etomoxir, a beta-oxidation inhib-
itor, during butyrate rescue experiments
showed that butyrate could no longer
normalize energy homeostasis in mito-
chondria, whereas an intervention with
another HDAC inhibitor, trichostatin A,
does not mimic the effects of butyrate.
Therefore, the effects of butyrate can be
unambiguously assigned to its assimila-
tion in energy metabolism.
Although the fact that colonocytes use
short chain fatty acids as fuel metabolites
is of common knowledge, this report ism 13, May 4, 2011 ª2011 Elsevier Inc. 489
Figure 1. How Gut Microbial Butyrate Prevents Autophagy in Colonocytes
Buyrate is produced by gut microbes and is considered a major source of energy for the colonocyte
through assimilation in TCA cycle, and as an HDAC inhibitor. Other short chain fatty acids (SCFA) also
modulate the physiology of the host through binding of G protein-coupled receptors (GPR), for instance.
By studying autophagy and energy metabolism in colonocytes from germ-free and conventionally raised
mice, Donohoe et al. show that the bioenergetic arm of butyrate goes beyond simple metabolism.
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Previewscritically important since it shows the
prevention of autophagy by butyrate.
The role of butyrate in preventing autoph-
agy is indirect but central: as one of the
main sources of energy for colonocytes,
it sustains their ATP levels and energy
homeostasis. The Donohoe study
integrates high-throughput data from
different platforms (transcriptome, pro-
teome, metabolome) to validate the
hypothesis that the gut microbiome and
the host interact symbiotically to regulate
energy homeostasis. This is a striking
example of how microbiome and chon-
driome cooperate to ensure the survival490 Cell Metabolism 13, May 4, 2011 ª2011of the karyome and the mammalian
eukaryotic cell (Figure 1).
Although the current study focuses on
butyrate and colonocytes, investigating
the interaction between microbial metab-
olites and other mammalian tissues
such as liver (Dumas et al., 2006) or
arteries (Wang et al., 2011) in the case of
methylamines should shed new light on
the fine regulation of human metabolism.
Butyrate, but also other bacterial small
molecules, can display one or several
properties: (1) fuel metabolite, (2) HDAC
inhibitor (Candido et al., 1978), and (3)
mammalian receptor binding propertiesElsevier Inc.(i.e. a ‘‘signaling metabolite’’). This work
of Donohoe et al. demonstrates that the
study of the microbial metabolites is now
moving toward assessing the direct the
consequences of their assimilation on
the cell biology of the host. Further studies
will document the influence of the gut
microbiome on other cell types eventually
leading to a systems-based under-
standing of the microbial-mammalian
metabolic axis.
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